ROYAL BANK OF CANADA - TRACON PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of TRACON PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$0264
-2.6%
0.00%
Q2 2023$0271
+1131.8%
0.00%
Q3 2022$0
-100.0%
22
-99.4%
0.00%
Q1 2022$11,0004,000
+399900.0%
0.00%
Q4 2019$010.00%
Other shareholders
TRACON PHARMACEUTICALS INC shareholders Q4 2023
NameSharesValueWeighting ↓
Opaleye Management Inc. 4,764,508$1,386,4720.33%
Ikarian Capital, LLC 2,765,530$804,7690.13%
JOHNSON & JOHNSON 84,003$24,4450.01%
BOOTHBAY FUND MANAGEMENT, LLC 258,844$75,3240.00%
Virtu Financial LLC 28,362$80.00%
LINDEN ADVISORS LP 454,916$132,3810.00%
BlackRock Inc. 267,719$77,9060.00%
Bank of New York Mellon Corp 10,259$2,9850.00%
HRT FINANCIAL LP 49,165$140.00%
MGO ONE SEVEN LLC 11,780$3,4280.00%
View complete list of TRACON PHARMACEUTICALS INC shareholders